Abstract
Diabetes mellitus type 2 is a metabolic disease associated with chronic hyperglycaemia, which leads to a wide range of complications, including microvascular and macrovascular alterations, retinopathy, nephropathy and renal disease or peripheral neuropathy. Several intracellular pathways have been shown to be associated to type 2 diabetes mellitus, ranging from an altered insulin receptor-associated signalling to an abnormal intracellular calcium homeostasis or disturbances in Na+ handling. A number of diabetes-associated complications have been reported to be associated with hyperactivity of certain protein tyrosine kinases, such as those cytosolic kinases of the Src family, involved in the altered intracellular calcium mobilisation and platelet-derived cardiovascular problems and in glomerular injury, or the JAK family of tyrosine kinases involved in hyperglycaemia-induced renal failure. There has been a considerable effort in several laboratories to identify suitable targets for the design of drugs against this disease. The development of tyrosine kinase inhibitors suitable for medical purposes might represent a significant advance in the therapy of complications associated to type 2 diabetes mellitus.
Keywords: Type 2 diabetes mellitus, calcium homeostasis, tyrosine kinases
Current Enzyme Inhibition
Title: Roles of Calcium and Tyrosine Kinases in the Pathogenesis of Type 2 Diabetes Mellitus
Volume: 2 Issue: 1
Author(s): J. A. Rosado, P. C. Redondo, J. A. Pariente and G. M. Salido
Affiliation:
Keywords: Type 2 diabetes mellitus, calcium homeostasis, tyrosine kinases
Abstract: Diabetes mellitus type 2 is a metabolic disease associated with chronic hyperglycaemia, which leads to a wide range of complications, including microvascular and macrovascular alterations, retinopathy, nephropathy and renal disease or peripheral neuropathy. Several intracellular pathways have been shown to be associated to type 2 diabetes mellitus, ranging from an altered insulin receptor-associated signalling to an abnormal intracellular calcium homeostasis or disturbances in Na+ handling. A number of diabetes-associated complications have been reported to be associated with hyperactivity of certain protein tyrosine kinases, such as those cytosolic kinases of the Src family, involved in the altered intracellular calcium mobilisation and platelet-derived cardiovascular problems and in glomerular injury, or the JAK family of tyrosine kinases involved in hyperglycaemia-induced renal failure. There has been a considerable effort in several laboratories to identify suitable targets for the design of drugs against this disease. The development of tyrosine kinase inhibitors suitable for medical purposes might represent a significant advance in the therapy of complications associated to type 2 diabetes mellitus.
Export Options
About this article
Cite this article as:
Rosado A. J., Redondo C. P., Pariente A. J. and Salido M. G., Roles of Calcium and Tyrosine Kinases in the Pathogenesis of Type 2 Diabetes Mellitus, Current Enzyme Inhibition 2006; 2 (1) . https://dx.doi.org/10.2174/157340806775473553
| DOI https://dx.doi.org/10.2174/157340806775473553 |
Print ISSN 1573-4080 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
Call for Papers in Thematic Issues
Recent Advances in Enzyme Inhibition Strategies for the Treatment and Management of Colorectal Cancer
Colorectal cancer (CRC) is among the leading causes of cancer-related morbidity and mortality worldwide, with therapeutic resistance and metastatic progression remaining major challenges. Enzyme inhibition has emerged as a promising strategy for CRC prevention and treatment, targeting key molecular pathways involved in tumor growth, invasion, and chemoresistance. This thematic issue ...read more
Related Journals
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nutritional Deficiency in Early Life Facilitates Aging-Associated Cognitive Decline
Current Alzheimer Research Hypertension and Angiogenesis
Current Pharmaceutical Design Cell Adhesion Molecules and Cadmium
Current Chemical Biology Crosstalk between Oxidative and Nitrosative Stress and Arterial Stiffness
Current Vascular Pharmacology MicroRNA-mediated MMP Regulation: Current Diagnostic and Therapeutic Strategies for Metabolic Syndrome
Current Gene Therapy Antioxidants in Treating Pathologies Involving Oxidative Damage: An Update on Medicinal Chemistry and Biological Activity of Stobadine and Related Pyridoindoles
Current Medicinal Chemistry Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach
Current Medicinal Chemistry A Review of Diabetes Mellitus and Exposure to the Environmental Toxicant Cadmium with an Emphasis on Likely Mechanisms of Action
Current Diabetes Reviews Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Metformin and Energy Metabolism in Breast Cancer: From Insulin Physiology to Tumour-initiating Stem Cells
Current Molecular Medicine Inflammatory Biomarkers and Therapeutic Targets in Heart Failure
Current Medicinal Chemistry In Vivo Beta-Cell Imaging with VMAT 2 Ligands - Current State-of-the-Art and Future Perspectives
Current Pharmaceutical Design Botanical Therapeutics (Part II): Antimicrobial and In Vitro Anticancer Activity against MCF7 Human Breast Cancer Cells of Chamomile, Parsley and Celery Alcoholic Extracts
Anti-Cancer Agents in Medicinal Chemistry Investigational Positive Inotropic Agents for Acute Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Molecular Imaging of Vascular Inflammation
Current Pharmaceutical Design Current Progress in Non-Invasive Imaging of Beta Cell Mass of the Endocrine Pancreas
Current Medicinal Chemistry Current Progress in Molecular Responses to Acidosis in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry Adenosine, Ketogenic Diet and Epilepsy: The Emerging Therapeutic Relationship Between Metabolism and Brain Activity
Current Neuropharmacology





